These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

161 related items for PubMed ID: 18759345

  • 1. Neurological effects of recombinant human erythropoietin in Friedreich's ataxia: a clinical pilot trial.
    Boesch S, Sturm B, Hering S, Scheiber-Mojdehkar B, Steinkellner H, Goldenberg H, Poewe W.
    Mov Disord; 2008 Oct 15; 23(13):1940-4. PubMed ID: 18759345
    [Abstract] [Full Text] [Related]

  • 2. Carbamylated erythropoietin increases frataxin independent from the erythropoietin receptor.
    Sturm B, Helminger M, Steinkellner H, Heidari MM, Goldenberg H, Scheiber-Mojdehkar B.
    Eur J Clin Invest; 2010 Jun 15; 40(6):561-5. PubMed ID: 20456483
    [Abstract] [Full Text] [Related]

  • 3. Friedreich's ataxia: clinical pilot trial with recombinant human erythropoietin.
    Boesch S, Sturm B, Hering S, Goldenberg H, Poewe W, Scheiber-Mojdehkar B.
    Ann Neurol; 2007 Nov 15; 62(5):521-4. PubMed ID: 17702040
    [Abstract] [Full Text] [Related]

  • 4. Effects of erythropoietin on frataxin levels and mitochondrial function in Friedreich ataxia--a dose-response trial.
    Nachbauer W, Hering S, Seifert M, Steinkellner H, Sturm B, Scheiber-Mojdehkar B, Reindl M, Strasak A, Poewe W, Weiss G, Boesch S.
    Cerebellum; 2011 Dec 15; 10(4):763-9. PubMed ID: 21597884
    [Abstract] [Full Text] [Related]

  • 5. Erythropoietin in Friedreich ataxia.
    Mariotti C, Nachbauer W, Panzeri M, Poewe W, Taroni F, Boesch S.
    J Neurochem; 2013 Aug 15; 126 Suppl 1():80-7. PubMed ID: 23859343
    [Abstract] [Full Text] [Related]

  • 6. Neurological effects of high-dose idebenone in patients with Friedreich's ataxia: a randomised, placebo-controlled trial.
    Di Prospero NA, Baker A, Jeffries N, Fischbeck KH.
    Lancet Neurol; 2007 Oct 15; 6(10):878-86. PubMed ID: 17826341
    [Abstract] [Full Text] [Related]

  • 7. Recombinant human erythropoietin: effects on frataxin expression in vitro.
    Sturm B, Stupphann D, Kaun C, Boesch S, Schranzhofer M, Wojta J, Goldenberg H, Scheiber-Mojdehkar B.
    Eur J Clin Invest; 2005 Nov 15; 35(11):711-7. PubMed ID: 16269021
    [Abstract] [Full Text] [Related]

  • 8. Safety and tolerability of carbamylated erythropoietin in Friedreich's ataxia.
    Boesch S, Nachbauer W, Mariotti C, Sacca F, Filla A, Klockgether T, Klopstock T, Schöls L, Jacobi H, Büchner B, vom Hagen JM, Nanetti L, Manicom K.
    Mov Disord; 2014 Jun 15; 29(7):935-9. PubMed ID: 24515352
    [Abstract] [Full Text] [Related]

  • 9. An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels.
    Yiu EM, Tai G, Peverill RE, Lee KJ, Croft KD, Mori TA, Scheiber-Mojdehkar B, Sturm B, Praschberger M, Vogel AP, Rance G, Stephenson SE, Sarsero JP, Stockley C, Lee CY, Churchyard A, Evans-Galea MV, Ryan MM, Lockhart PJ, Corben LA, Delatycki MB.
    J Neurol; 2015 May 15; 262(5):1344-53. PubMed ID: 25845763
    [Abstract] [Full Text] [Related]

  • 10. Erythropoietin in Friedreich ataxia: no effect on frataxin in a randomized controlled trial.
    Mariotti C, Fancellu R, Caldarazzo S, Nanetti L, Di Bella D, Plumari M, Lauria G, Cappellini MD, Duca L, Solari A, Taroni F.
    Mov Disord; 2012 Mar 15; 27(3):446-9. PubMed ID: 22411849
    [Abstract] [Full Text] [Related]

  • 11. Bioenergetics of the calf muscle in Friedreich ataxia patients measured by 31P-MRS before and after treatment with recombinant human erythropoietin.
    Nachbauer W, Boesch S, Schneider R, Eigentler A, Wanschitz J, Poewe W, Schocke M.
    PLoS One; 2013 Mar 15; 8(7):e69229. PubMed ID: 23922695
    [Abstract] [Full Text] [Related]

  • 12. Open-label pilot study of interferon gamma-1b in Friedreich ataxia.
    Seyer L, Greeley N, Foerster D, Strawser C, Gelbard S, Dong Y, Schadt K, Cotticelli MG, Brocht A, Farmer J, Wilson RB, Lynch DR.
    Acta Neurol Scand; 2015 Jul 15; 132(1):7-15. PubMed ID: 25335475
    [Abstract] [Full Text] [Related]

  • 13. Application of a Scale for the Assessment and Rating of Ataxia (SARA) in Friedreich's ataxia patients according to posturography is limited.
    Schwabova J, Maly T, Laczo J, Zumrova A, Komarek V, Musova Z, Zahalka F.
    J Neurol Sci; 2014 Jun 15; 341(1-2):64-7. PubMed ID: 24768059
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. GIFT-1, a phase IIa clinical trial to test the safety and efficacy of IFNγ administration in FRDA patients.
    Marcotulli C, Fortuni S, Arcuri G, Tomassini B, Leonardi L, Pierelli F, Testi R, Casali C.
    Neurol Sci; 2016 Mar 15; 37(3):361-4. PubMed ID: 26621361
    [Abstract] [Full Text] [Related]

  • 16. Therapeutic Prospects for Friedreich's Ataxia.
    Zhang S, Napierala M, Napierala JS.
    Trends Pharmacol Sci; 2019 Apr 15; 40(4):229-233. PubMed ID: 30905359
    [Abstract] [Full Text] [Related]

  • 17. Triple therapy with deferiprone, idebenone and riboflavin in Friedreich's ataxia - open-label trial.
    Arpa J, Sanz-Gallego I, Rodríguez-de-Rivera FJ, Domínguez-Melcón FJ, Prefasi D, Oliva-Navarro J, Moreno-Yangüela M.
    Acta Neurol Scand; 2014 Jan 15; 129(1):32-40. PubMed ID: 23668357
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. A longitudinal VBM study monitoring treatment with erythropoietin in patients with Friedreich ataxia.
    Santner W, Schocke M, Boesch S, Nachbauer W, Egger K.
    Acta Radiol Short Rep; 2014 May 15; 3(4):2047981614531573. PubMed ID: 25298866
    [Abstract] [Full Text] [Related]

  • 20. Skeletal muscle involvement in friedreich ataxia and potential effects of recombinant human erythropoietin administration on muscle regeneration and neovascularization.
    Nachbauer W, Boesch S, Reindl M, Eigentler A, Hufler K, Poewe W, Löscher W, Wanschitz J.
    J Neuropathol Exp Neurol; 2012 Aug 15; 71(8):708-15. PubMed ID: 22805773
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.